Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)

Drug Reaction Clinical Trial

Official title:
Drug Patch Tests, Enzyme-linked Immunosorbent Spot Assay (Elispot) and Lymphocyte Transformation Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)

Status Recruiting

Clinical Trial Summary

The study is about drug patch tests in patients who have history of severe cutaneous drug reaction including Steven Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), Drug-induced eosinophilia and systemic symptoms (DRESS), AGEP (Acute generalized exanthematous pustulosis) and generalized bullous fixed drug eruptions. This study also investigate in Enzyme-linked immunosorbent spot assay (ELIspot) and lymphocyte transformation test. We also trying to prove the correlation among result of drug patch tests, ELIspot and LTT.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Drug Reaction
Drug-Related Side Effects and Adverse Reactions

Clinical Trial Details

NCT number	NCT03176342
Study type	Interventional
Source	Chulalongkorn University
Contact
Status	Recruiting
Phase	N/A
Start date	August 4, 2016
Completion date	August 3, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03635684` - Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen	Phase 2
Recruiting	`NCT03779347` - Schistosomiasis Diagnosis Using a CAA Antigen Test	Phase 3
Recruiting	`NCT03270839` - Motion Sickness Medications and Vestibular Time Constant	Phase 4
Not yet recruiting	`NCT03585946` - Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Active, not recruiting	`NCT06428162` - An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community
Completed	`NCT03839186` - Pharmacogenetics Study on the Effects of Anesthetic Drugs on Circulatory Function